The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A

BACKGROUND: Amifostine (WR-2721, delivered as Ethyol(®)) is a phosphorylated aminothiol compound clinically used in addition to cis-platinum to reduce the toxic side effects of therapeutic treatment on normal cells without reducing their efficacy on tumour cells. Its mechanism of action is attribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Dedieu, S, Canron, X, Rezvani, HR, Bouchecareilh, M, Mazurier, F, Sinisi, R, Zanda, M, Moenner, M, Bikfalvi, A, North, S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859403/
https://www.ncbi.nlm.nih.gov/pubmed/20334641
http://dx.doi.org/10.1186/1741-7015-8-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859403/
https://www.ncbi.nlm.nih.gov/pubmed/20334641
http://dx.doi.org/10.1186/1741-7015-8-19

Ejemplares similares